AI Super Agents: What They Are and Their Potential Global Health Impact Artificial General Intelligence (AGI) represents a significant advancement in AI, with the potential to...
Post-traumatic stress disorder and anxiety are associated with lower levels of anti-Müllerian hormone, a marker of ovarian reserve, among women firefighters, new research has found. The...
SiS Solve, a global leader in driving innovation within women’s health, has announced the launch of SiS Solve New York 2025, a pitch event offering over...
Innovative Birmingham-based nutrition firm Rem3dy Health has been recognised in the first-ever “Sunday Times 100 Tech: Britain’s fastest-growing private technology companies” list. The new rankings were...
A clinical trial has found that, in patients with high-risk HER2-positive breast cancer, post-surgery, or adjuvant, treatment with trastuzumab emtansine (T-DM1) reduced the long-term risk of...
Future Fertility has developed a significant advancement in reproductive care with the launch of Euploidy Insights. This clinically validated, non-invasive tool analyses freshly retrieved oocytes to predict...
Researchers have discovered how specific protein regions contribute to breast cancer, potentially paving the way for new treatment. The discovery also offers scientists new tools and...
The Femtech World Awards 2025, delivered in partnership with headline sponsor Planned Parenthood, celebrates the brightest lights in women’s health innovation. We will be celebrating some...
Machine learning models can more quickly and affordably identify women with severe subjective cognitive decline during the menopause transition, effectively opening the door to better management...
A new study underscores the potential of the RAD51 biomarker in tailoring treatment strategies in patients with early breast cancer. A test based on the detection...
